Hassabis at I/O 2026: the singularity is already here, or almost

Demis Hassabis closed Google I/O 2026 with a statement he described as a profound moment for humanity. The CEO of DeepMind suggested that the current breakthrough could mark the beginning of the singularity, pointing to the arrival of Artificial General Intelligence. As proof, he presented Gemini for Science, a set of tools designed to accelerate drug discovery and, in his words, cure all diseases.

Demis Hassabis on a futuristic stage at Google I/O 2026, holding a glowing holographic molecular crystal while a translucent screen shows Gemini for Science analyzing protein structures in real time, synthetic drugs forming in nanovials under blue light, AI algorithms visualized as pulsing lines of code connecting genomic data, a tech audience watching, a background with cobalt blue and graphene LED panels, hyperrealistic cinematic style, dramatic studio lighting, photorealistic technical render, metallic and glass textures, atmosphere of a historic revelation

Gemini for Science: the lab that doesn't need white coats 🧬

DeepMind's new platform integrates language models with molecular simulations and genomic data analysis. Gemini for Science allows researchers to formulate hypotheses, run virtual experiments, and predict results in minutes. The system has already identified three promising new compounds against pancreatic cancer, a process that would have taken years in a traditional lab. Hassabis stated that the tool could reduce the drug development cycle to months.

Cure all diseases... and then the cold coffee ☕

Hassabis assured that AGI will cure all diseases, but attendees wondered if it could first fix the venue's WiFi. While Gemini for Science promises to defeat cancer, everyday users dream of an AI that doesn't freeze when opening email. For now, humanity will have to settle for the singularity arriving just in time to explain why the coffee from the machine always tastes like wet cardboard.